You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Asymptomatic brain metastases

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small-cell Lung Cancer, Brain Metastases Trial in United States (Carboplatin, Etoposide, Atezolizumab)

Active, not recruiting
  • Small-cell Lung Cancer
  • Brain Metastases
  • Duarte, California
  • +5 more
Oct 10, 2022

Asymptomatic Brain Metastases, Driver Mutation Positive NSCLC Trial in Mumbai (Stereotactic radiosurgery/whole brain

Recruiting
  • Asymptomatic Brain Metastases
  • Driver Mutation Positive Non-small Cell Lung Cancer
  • Stereotactic radiosurgery/whole brain radiotherapy
  • Tyrosine kinase inhibitor
  • Mumbai, Maharashtra, India
    Tata Memorial Hospital
Feb 2, 2022

Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • (no location specified)
Aug 4, 2023

Metastatic Melanoma Trial in New York (Lifileucel (LN-144))

Recruiting
  • Metastatic Melanoma
  • Lifileucel (LN-144)
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Jan 23, 2023

Lung Cancer Trial in Jerusalem (AZD9291)

Active, not recruiting
  • Lung Cancer
  • Jerusalem, Israel
    Shaare Zedek
Aug 29, 2021

NSCLC Trial (Pemetrexed, Carboplatin, Pembrolizumab, Paclitaxel, Carboplatin, Pembrolizumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Pemetrexed, Carboplatin, Pembrolizumab
  • Paclitaxel, Carboplatin, Pembrolizumab
  • (no location specified)
Jul 8, 2021

NSCLC, EGFR Gene Mutation, EGF-R Positive NSCLC Trial in Jerusalem (Stereotactic surgery)

Recruiting
  • NSCLC
  • +4 more
  • Stereotactic surgery
  • Jerusalem, Israel
    Hadassah Ein Kerem Medical Center
Aug 30, 2021

Lung Tumors Trial in Gyeonggi-do, Incheon, Seoul (lazertinib(YH25448))

Recruiting
  • Lung Neoplasms
  • Gyeonggi-do, Korea, Republic of
  • +5 more
Apr 19, 2022

NSCLC Trial in Gyeonggi-do, Incheon, Seoul (Lazertinib, Pemetrexed, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Gyeonggi-do, Korea, Republic of
  • +5 more
Jul 25, 2022

Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • +2 more
  • (no location specified)
Aug 11, 2023

Brain Metastases: Value ofLongitudinal Multimodal Approach

Recruiting
  • Brain Metastases, Adult
    • Brest, France
      Chu Brest
    Sep 6, 2023

    Metastatic NSCLC MET Exon 14 Skipping Mutation and Brain

    Completed
    • Metastatic Non-Small Cell Lung Cancer
    • East Hanover, New Jersey
      18 Novartis Investigative Sites in the US
    Dec 29, 2022

    NSCLC Trial in Pittsburgh (Tiragolumab, Atezolizumab, Pemetrexed)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Feb 16, 2023

    Brain Metastases, Nonsmall Cell Lung Cancer Stage III Trial in Winston-Salem (MRI of the Brain, Blood draws, Quality of Life

    Not yet recruiting
    • Brain Metastases
    • Nonsmall Cell Lung Cancer Stage III
    • MRI of the Brain
    • +2 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Cente
    Jan 19, 2023

    Brain Metastases, Radiotherapy Trial in Heidelberg (Preoperative Radiotherapy, Intraoperative Radiation, Postoperative

    Not yet recruiting
    • Brain Metastases
    • Radiotherapy
    • Preoperative Radiotherapy
    • +2 more
    • Heidelberg, Germany
      Department of Radiotherapy, University of Heidelberg
    May 12, 2023

    NSCLC Trial in Pittsburgh (Capmatinib)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jan 9, 2023

    Breast Cancer, Brain Metastases, Radiotherapy Trial in Shanghai (Combination use of SRT with T-DXd)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Combination use of SRT with T-DXd
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 14, 2023

    Lung Adenocarcinoma Trial in Shijiazhuang (Tislelizumab,Platinum)

    Recruiting
    • Lung Adenocarcinoma
    • Shijiazhuang, Hebei, China
      The Fourth Hospital of Hebei Medical University (Hebei Tumor Hos
    Sep 24, 2023

    Brain Metastases, Radionecrosis, Pulmonary Cancer Trial in Paris (MRI with CEST sequence, IVIM and ASL sequence)

    Not yet recruiting
    • Brain Metastases
    • +2 more
    • MRI with CEST sequence, IVIM and ASL sequence
    • Paris, France
      Hôpital Bichat-Claude Bernard
    Aug 3, 2023

    NSCLC Metastatic Trial in Shanghai (Almonertinib, SBRT)

    Recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 23, 2023

    Breast Cancer With Brain Metastases Trial in Wuhan (pyrotinib+capecitabine+bevacizumab)

    Recruiting
    • Breast Cancer With Brain Metastases
    • Wuhan, Hubei, China
      Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
    Nov 22, 2023

    Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)

    Not yet recruiting
    • Breast Cancer
    • Brain Metastases
    • Brain Imaging with 18F-FES
    • New York, New York
      New York-Presbyterian/Weill Cornell Medical Center
    Oct 2, 2023

    Breast Cancer Brain Metastases Trial in Guangzhou (SPH4336 Tablets)

    Not yet recruiting
    • Breast Cancer Brain Metastases
    • SPH4336 Tablets
    • Guangzhou, Guangdong, China
      Affiliated Cancer Hospital, Sun Yat-sen University
    May 24, 2023

    Non Small Cell Lung Cancer Trial in Nashville (AMG 510, MVASI)

    Recruiting
    • Non Small Cell Lung Cancer
    • Nashville, Tennessee
      Vanderbilt Ingram Cancer Center
    Jun 28, 2022

    NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591, Osimertinib)

    Not yet recruiting
    • NSCLC
    • +2 more
    • Beijing, Beijing, China
      National Cancer Center/Cancer Hospitial,Chinese Academy of Medic
    Jul 9, 2023